Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) is surging on reports by Bloomberg that the company is exploring strategic alternatives, which would imply a potential merger or acquisition of or by the company. Shares are now up 13.5% at $42.85 on over 5-times normal trading volume of 5.8 million shares with more than one-hour until the close. Shares hit a new 52-week high of $46.07 today.
Contact [email protected] for any questions or corrections.